<HTML>
<!-- Produced by edgar-services.com using EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2020 [PPXV9M0ULJ50VJXL0P8L]. www.edgarsuite.com -->
<HEAD>
<TITLE>UNITED STATES</TITLE>
</HEAD>
<BODY>
<DIV style=margin-left:72pt;width:468pt><P align=center style='font:11.5pt Times New Roman;margin:0'>UNITED STATES<BR>SECURITIES AND EXCHANGE COMMISSION<BR>Washington, D.C. 20549</P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:12pt Times New Roman;margin:0'><B>FORM 8-K</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:11pt Times New Roman;margin:0'><B>CURRENT REPORT</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:11pt Times New Roman;margin:0'><B>Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</B></P>
<P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:11pt Times New Roman;margin:0'>Date of Report (Date of earliest event reported): &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;October 1, 2020</P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:9pt Times New Roman;margin:0'><FONT style='font-size:14pt;border-bottom:1px solid #000000'><B>VITRO DIAGNOSTICS, INC.</B></FONT><BR>(Exact Name of Registrant as Specified in its Charter)</P>
<P style='font:9pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE align=center style=border-collapse:collapse><TR><TD valign=top style=width:170.95pt><P style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;Nevada&#160;&#160;&#160;&#160;&#160;&#160;&#160;</FONT></P>
</TD><TD valign=top style=width:126.05pt><P style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;0-17378&#160;&#160;&#160;&#160;&#160;&#160;&#160;</FONT></P>
</TD><TD valign=top style=width:139.5pt><P style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>&#160;&#160;&#160;&#160;84-1012042&#160;&#160;&#160;&#160;</FONT></P>
</TD></TR>
<TR><TD valign=top style=width:170.95pt><P style='font:9pt Times New Roman;margin:0'>(State or other jurisdiction<BR> of incorporation)</P>
</TD><TD valign=top style=width:126.05pt><P style='font:9pt Times New Roman;margin:0'>Commission File<BR>Number</P>
</TD><TD valign=top style=width:139.5pt><P style='font:9pt Times New Roman;margin:0'>(I.R.S. Employer Identification number)</P>
</TD></TR>
</TABLE>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:9pt Times New Roman;margin:0'><FONT style='font-size:11pt;border-bottom:1px solid #000000'>4621 Technology Drive, Golden CO &nbsp;80403</FONT><BR>(Address of principal executive offices)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(Zip Code)</P>
<P align=center style='font:8pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:11pt Times New Roman;margin:0'>Registrant's telephone number, including area code:&#160;&#160;&#160;<FONT style='border-bottom:1px solid #000000'>(303) 999-2130</FONT></P>
<P align=center style='font:9pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:9pt Times New Roman;margin:0'>______________________________________________________</P>
<P align=center style='font:9pt Times New Roman;margin:0'>(Former name or former address, if changed since last report)</P>
<P align=center style='font:9pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11.5pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE style=border-collapse:collapse;width:478.8pt><TR><TD valign=top style=width:41.4pt><P style='font:11.5pt Times New Roman;margin:0'>___</P>
</TD><TD valign=top style=width:437.4pt><P style='font:11.5pt Times New Roman;margin:0'>Written communications pursuant to Rule 425 under the Securities Act </P>
</TD></TR>
<TR><TD valign=top style=width:41.4pt><P style='font:11.5pt Times New Roman;margin:0'>___</P>
</TD><TD valign=top style=width:437.4pt><P style='font:11.5pt Times New Roman;margin:0'>Soliciting material pursuant to Rule 14a-12 under the Exchange Act</P>
</TD></TR>
<TR><TD valign=top style=width:41.4pt><P style='font:11.5pt Times New Roman;margin:0'>___</P>
</TD><TD valign=top style=width:437.4pt><P style='font:11.5pt Times New Roman;margin:0'>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act</P>
</TD></TR>
<TR><TD valign=top style=width:41.4pt><P style='font:11.5pt Times New Roman;margin:0'>___</P>
</TD><TD valign=top style=width:437.4pt><P style='font:11.5pt Times New Roman;margin:0'>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act</P>
</TD></TR>
</TABLE>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>Securities registered pursuant to Section 12(b) of the Act:</B></P>
<P style='font:10pt Times New Roman;margin:0'>&#160;</P>
<TABLE style=border-collapse:collapse;width:100%><TR><TD valign=top style='width:33.34%;border-bottom:1pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'><B>Title of each Class</B></P>
</TD><TD valign=top style='width:33.34%;border-bottom:1pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'><B>Trading Symbol</B></P>
</TD><TD valign=top style='width:33.34%;border-bottom:1pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'><B>Name of each exchange on which registered</B></P>
</TD></TR>
<TR><TD valign=top><P align=center style='font:10pt Times New Roman;margin:0'>N/A</P>
</TD><TD valign=top><P align=center style='font:10pt Times New Roman;margin:0'>N/A</P>
</TD><TD valign=top><P align=center style='font:10pt Times New Roman;margin:0'>N/A</P>
</TD></TR>
</TABLE>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11.5pt Times New Roman;margin-top:7.4pt;margin-bottom:0pt;margin-right:5.9pt'><FONT style=color:#231F20>Indicate by check mark whether the registrant is an emerging growth company as de&#64257;ned in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</FONT></P>
<P style='font:11.5pt Times New Roman;margin-top:0.5pt;margin-bottom:0pt'>&nbsp;</P>
<P style='font:11.5pt Times New Roman;margin:0;margin-left:36pt'><KBD style='position:absolute;font:11.5pt Times New Roman;margin-left:36pt'><FONT style=color:#231F20>Emerging growth company</FONT></KBD><KBD style=margin-left:324pt></KBD><FONT style=color:#231F20>[ X ]</FONT>&nbsp;</P>
<P style='font:11.5pt Times New Roman;margin-top:0.15pt;margin-bottom:0pt'>&nbsp;</P>
<P style='font:11.5pt Times New Roman;margin-top:3.7pt;margin-bottom:0pt;margin-right:32.3pt'><FONT style=color:#231F20>If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised &#64257;nancial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</FONT>&nbsp;&nbsp;<FONT style=color:#231F20>[ &nbsp;&nbsp;&nbsp;&nbsp;]</FONT></P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style=line-height:0;margin:0></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11.5pt Times New Roman;margin:0'><KBD style='position:absolute;font:11.5pt Times New Roman;margin-left:0pt'><FONT style='border-bottom:1px solid #000000'><B>ITEM 2.02</B></FONT></KBD><KBD style=margin-left:72pt></KBD><FONT style='border-bottom:1px solid #000000'><B>RESULTS OF OPERATION AND FINANCIAL CONDITION</B></FONT>&nbsp;</P>
<P style='font:11.5pt Times New Roman;margin:0'><KBD style='position:absolute;font:11.5pt Times New Roman;margin-left:0pt'><FONT style='border-bottom:1px solid #000000'><B>ITEM 7.01</B></FONT></KBD><KBD style=margin-left:72pt></KBD><FONT style='border-bottom:1px solid #000000'><B>REGULATION FD DISCLOSURE</B></FONT>&nbsp;</P>
<P style='font:11.5pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:12pt Times New Roman;margin:0'>On October 1, 2020, Vitro Diagnostics, Inc., a Nevada corporation (the &#8220;Company&#8221;) issued a press release announcing results of operations and financial condition for its fiscal 3<SUP>rd</SUP> quarter year ended July 31, 2020. &nbsp; A copy of the Press Release is filed herewith as Exhibit 99.1.</P>
<P style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:12pt Times New Roman;margin:0'>The information in this Current Report on Form 8-K furnished pursuant to Item 7.01, including Exhibit 99.1, shall not be deemed to be &#8220;filed&#8221; for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to liability under that section, and they shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. By filing this Current Report on Form 8-K and furnishing this information pursuant to Item 7.01, The Company makes no admission as to the materiality of any information in this Current Report on Form 8-K, including Exhibit 99.1, that is required to be disclosed solely by Regulation FD. </P>
<P style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11.5pt Times New Roman;margin-top:5pt;margin-bottom:5pt'>&nbsp;</P>
<P style='font:11.5pt Times New Roman;margin:0'><KBD style='position:absolute;font:11.5pt Times New Roman;margin-left:0pt'><FONT style='border-bottom:1px solid #000000'><B>ITEM 9.01</B></FONT><B>:</B></KBD><KBD style=margin-left:72pt></KBD><FONT style='border-bottom:1px solid #000000'><B>EXHIBITS</B></FONT>&nbsp;</P>
<P style='font:11.5pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE style=border-collapse:collapse;width:478.8pt><TR><TD valign=top style=width:36.9pt><P style='font:11.5pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:45pt><P style='font:11.5pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Item</FONT></P>
</TD><TD valign=top style=width:396.9pt><P style='font:11.5pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Title</FONT></P>
</TD></TR>
<TR><TD valign=top style=width:36.9pt><P style='font:11.5pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:45pt><P style='font:11.5pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:396.9pt><P style='font:11.5pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:36.9pt><P style='font:11.5pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:45pt><P style='font:11.5pt Times New Roman;margin:0'>99.1</P>
</TD><TD valign=top style=width:396.9pt><P style='font:11.5pt Times New Roman;margin:0'><A href=vitro_ex99z1.htm style=text-decoration:none><FONT style='color:#0563C1;border-bottom:1px solid #0563C1'>Press Release</FONT></A></P>
</TD></TR>
</TABLE>
<P style='font:11.5pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:11.5pt Times New Roman;margin:0'><B>SIGNATURES</B></P>
<P style='font:11.5pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11.5pt Times New Roman;margin:0'>Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</P>
<P style='font:11.5pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE style=border-collapse:collapse><TR><TD valign=top style=width:32.4pt><P style='font:11.5pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:207pt><P style='font:11.5pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD colspan=2 valign=top style=width:239.4pt><P style='font:11.5pt Times New Roman;margin:0'><B>Vitro Diagnostics, Inc. </B><BR>(Registrant)</P>
</TD></TR>
<TR><TD valign=top style=width:32.4pt><P style='font:11.5pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:207pt><P style='font:11.5pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:13.5pt><P style='font:11.5pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:225.9pt><P style='font:11.5pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:27pt><TD valign=top style=width:32.4pt><P style='font:11.5pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:207pt><P style='font:11.5pt Times New Roman;margin:0'>Dated: <FONT style='border-bottom:1px solid #000000'>October 1, 2020</FONT></P>
</TD><TD valign=top style=width:13.5pt><P style='font:11.5pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:225.9pt><P style='font:11.5pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'><I>/s/ James R. Musick</I></FONT><BR>James R. Musick, President and CEO</P>
</TD></TR>
<TR style=height:27pt><TD valign=top style=width:32.4pt><P style='font:11.5pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:207pt><P style='font:11.5pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:13.5pt><P style='font:11.5pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:225.9pt><P style='font:11.5pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
</TABLE>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>2</P>
</DIV>
</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "vitro_8k.htm", "description": "CURRENT EVENT REPORT - FORM 8-K", "secsgml_size_bytes": 13890}]
{"company-data": {"conformed-name": "VITRO DIAGNOSTICS INC", "cik": "0000793171", "assigned-sic": "2836", "irs-number": "841012042", "state-of-incorporation": "NV", "fiscal-year-end": "1031"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-17378", "film-number": "201224526"}, "business-address": {"street1": "4621 TECHNOLOGY DRIVE", "city": "GOLDEN", "state": "CO", "zip": "80403", "phone": "(720) 859-4120"}, "mail-address": {"street1": "4621 TECHNOLOGY DRIVE", "city": "GOLDEN", "state": "CO", "zip": "80403"}, "former-company": [{"former-conformed-name": "LABTEK INC", "date-changed": "19870217"}, {"former-conformed-name": "IMPERIAL MANAGEMENT INC", "date-changed": "19870201"}]}
UNITED STATES
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):       October 1, 2020
VITRO DIAGNOSTICS, INC.
(Exact Name of Registrant as Specified in its Charter)
Nevada
0-17378
84-1012042
(State or other jurisdiction
of incorporation)
Commission File
Number
(I.R.S. Employer Identification number)
4621 Technology Drive, Golden CO  80403
(Address of principal executive offices)                    (Zip Code)
Registrant's telephone number, including area code:
(303) 999-2130
______________________________________________________
(Former name or former address, if changed since last report)
___
Written communications pursuant to Rule 425 under the Securities Act
___
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
___
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
___
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act
Securities registered pursuant to Section 12(b) of the Act:
Title of each Class
Trading Symbol
Name of each exchange on which registered
N/A
N/A
N/A
Indicate by check mark whether the registrant is an emerging growth company as deﬁned in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
[ X ]
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised ﬁnancial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
[     ]
ITEM 2.02
RESULTS OF OPERATION AND FINANCIAL CONDITION
ITEM 7.01
REGULATION FD DISCLOSURE
On October 1, 2020, Vitro Diagnostics, Inc., a Nevada corporation (the "Company") issued a press release announcing results of operations and financial condition for its fiscal 3
rd
quarter year ended July 31, 2020.   A copy of the Press Release is filed herewith as Exhibit 99.1.
The information in this Current Report on Form 8-K furnished pursuant to Item 7.01, including Exhibit 99.1, shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to liability under that section, and they shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. By filing this Current Report on Form 8-K and furnishing this information pursuant to Item 7.01, The Company makes no admission as to the materiality of any information in this Current Report on Form 8-K, including Exhibit 99.1, that is required to be disclosed solely by Regulation FD.
ITEM 9.01
:
EXHIBITS
Item
Title
99.1
Press Release
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Vitro Diagnostics, Inc.
(Registrant)
Dated:
October 1, 2020
/s/ James R. Musick
James R. Musick, President and CEO
2